Informations générales
  • Catégorie de maladie Maladies du système nerveux (BASEC)
  • Study Phase N/A (ICTRP)
  • État du recrutement recrutement en cours (BASEC/ICTRP)
  • Lieu de l’étude
    Zurich
    (BASEC)
  • Responsable de l'étude Jannis Fischer jannis.fischer@positrigo.com (BASEC)
  • Source(s) de données BASEC: Importé de 06.05.2025 ICTRP: Importé de 13.06.2025
  • Date de mise à jour 13.06.2025 02:00
HumRes64953 | SNCTP000005899 | BASEC2023-D0106 | NCT06344871

Exploratory study of NeuroLF, a medical trial product without CE marking for PET imaging of the human brain

  • Catégorie de maladie Maladies du système nerveux (BASEC)
  • Study Phase N/A (ICTRP)
  • État du recrutement recrutement en cours (BASEC/ICTRP)
  • Lieu de l’étude
    Zurich
    (BASEC)
  • Responsable de l'étude Jannis Fischer jannis.fischer@positrigo.com (BASEC)
  • Source(s) de données BASEC: Importé de 06.05.2025 ICTRP: Importé de 13.06.2025
  • Date de mise à jour 13.06.2025 02:00

Résumé de l'étude

For this study, patients will be recruited who are scheduled for a regular clinical PET scan. By participating, they will stay a little longer in the hospital during this single appointment, and an additional image will be taken on the NeuroLF prototype alongside the regular PET image. This will take up to one hour longer than the visit would normally last.

(BASEC)

Intervention étudiée

Brain PET scan

(BASEC)

Maladie en cours d'investigation

Functional diseases of the brain, e.g., Alzheimer's disease

(BASEC)

Critères de participation
• Ability to sit still in the pure head PET scanner for 15 minutes • You are scheduled for a regular brain PET examination as part of the clinical routine. • Male and female patients aged 18 to 80 years (BASEC)

Critères d'exclusion
• Contraindications for a PET examination, • Metal implants in the head, • Pregnant and breastfeeding women, (BASEC)

Lieu de l’étude

Zurich

(BASEC)

Germany, Switzerland (ICTRP)

Sponsor

Positrigo AG

(BASEC)

Contact pour plus d'informations sur l'étude

Personne de contact en Suisse

Jannis Fischer

+41 44 5155331

jannis.fischer@positrigo.com

Positrigo AG

(BASEC)

Informations générales

+41445155331

jannis.fischer@positrigo.com

(ICTRP)

Informations scientifiques

+41445155331

jannis.fischer@positrigo.com

(ICTRP)

Nom du comité d'éthique approbateur (pour les études multicentriques, uniquement le comité principal)

Commission cantonale de Zurich

(BASEC)

Date d'approbation du comité d'éthique

14.05.2024

(BASEC)


Identifiant de l'essai ICTRP
NCT06344871 (ICTRP)

Titre officiel (approuvé par le comité d'éthique)
EXPLORATORY STUDY OF NEUROLF, AN INVESTIGATIONAL MEDICAL DEVICE WITHOUT CE-MARKING FOR PET IMAGING OF THE HUMAN BRAIN (BASEC)

Titre académique
Exploratory Study of NeuroLF, an Investigational Medical Device Without CE Marking for PET Imaging of the Human Brain (ICTRP)

Titre public
Exploratory Study Using a New Head-only PET Scanner / ExploreNeuroLF (ICTRP)

Maladie en cours d'investigation
Brain Diseases (ICTRP)

Intervention étudiée
Device: NeuroLFDevice: Conventional PET scan (ICTRP)

Type d'essai
Interventional (ICTRP)

Plan de l'étude
Allocation: Non-Randomized. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label). (ICTRP)

Critères d'inclusion/exclusion
Inclusion Criteria:

- Capable of giving Informed Consent as documented by signature (Appendix Informed
Consent Form).

- Ability to sit still in the head-only PET scanner for 15 minutes.

- Are scheduled to receive a regular brain PET scan as part of clinical routine.

- Male and Female patients 18 years to 80 years of age.

Exclusion Criteria:

- Contraindications to PET examination,

- Patient height smaller than 160 cm or taller than 200 cm,

- Patient weight more than 120 kg,

- Patient cannot sit upright for at least 15 minutes,

- Metal implants in the head,

- Pregnant or Breastfeeding women,

- Known or suspected non-compliance, drug or alcohol abuse,

- Inability to follow the procedures of the study, e.g. due to language problems,
psychological disorders, dementia, etc. of the participant,

- Participation in another study with investigational drug/device within the 30 days
preceding and during the present study,

- Previous enrolment into the current study,

- Enrolment of the investigator, his/her family members, employees and other dependent
persons. (ICTRP)

non disponible

Critères d'évaluation principaux et secondaires
PET Image of the Brain (ICTRP)

Ease of Placement (Usability);Usage of accessories for patient placement (Usability) (ICTRP)

Date d'enregistrement
non disponible

Inclusion du premier participant
non disponible

Sponsors secondaires
University of Zurich;University of Leipzig (ICTRP)

Contacts supplémentaires
Jannis Fischer, Dr., jannis.fischer@positrigo.com, +41445155331 (ICTRP)

ID secondaires
002 (ICTRP)

Résultats-Données individuelles des participants
non disponible

Informations complémentaires sur l'essai
https://clinicaltrials.gov/ct2/show/NCT06344871 (ICTRP)

Résultats de l'essai

Résumé des résultats

non disponible

Lien vers les résultats dans le registre primaire

non disponible